Cloning, and expression in Escherichia coli K-12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa.

Journal of Bacteriology
K ColemanJ P Arbuthnott

Abstract

A hemolysin determinant was cloned from Pseudomonas aeruginosa PA103 by inserting Sau3a-generated DNA fragments between the BamHI sites of the lambda replacement vector WL47.1. A 9.5-kilobase HindIII fragment encoding the hemolysin was subcloned from this phage and inserted into the plasmid vector pHC79 to generate the recombinant plasmid pKC95. Escherichia coli K-12 strains harboring pKC95 exhibited zones of hemolysis after several days of growth on blood agar plates. Hemolysis was shown to be due to phospholipase C activity by using the chromogenic substrate p-nitrophenylphosphorylcholine. Deletion mutants of pKC95 were isolated, and polypeptides expressed from these plasmids were examined by using the E. coli minicell system. A polypeptide of 78,000 daltons was associated with phospholipase C activity. The hemolytic activity was cell associated when expressed in E. coli.

References

Aug 1, 1979·Infection and Immunity·M W Stinson, C Hayden
Jan 7, 1977·Molecular & General Genetics : MGG·N E MurrayK Murray
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·Y HirotaS Yasuda
Mar 7, 1977·Molecular & General Genetics : MGG·G Dougan, D Sherratt
Nov 1, 1974·The Journal of Infectious Diseases·P V Liu
Jan 1, 1981·Annual Review of Genetics·M N Hall, T J Silhavy
Jun 1, 1961·Journal of Bacteriology·M T ESSELMANN, P V LIU
Mar 1, 1961·The Journal of Infectious Diseases·P V LIUJ L BATES

❮ Previous
Next ❯

Citations

Apr 22, 1985·FEBS Letters·B L PasloskeW Paranchych
Feb 9, 2011·Applied Biochemistry and Biotechnology·Lata Ramrakhiani, Subhash Chand
Nov 1, 1989·Journal of Clinical Microbiology·D P SpeertW Paranchych
Jan 1, 1984·Journal of Bacteriology·M J StapletonR L Warren
Oct 1, 1984·Journal of Bacteriology·S L Goldberg, J R Murphy
Sep 1, 1986·Infection and Immunity·C Gonzalez-RayosT J Beveridge
Feb 1, 1986·Journal of Bacteriology·B B FinlayW Paranchych
Jun 1, 1987·Microbiological Reviews·A Guidolin, P A Manning
Jan 11, 2000·Clinical Microbiology Reviews·M A Ghannoum
Apr 1, 1990·Microbial Pathogenesis·P A SokolD E Woods
Nov 26, 1986·Biochemical and Biophysical Research Communications·W KugimiyaY Takagi
Oct 1, 1988·Infection and Immunity·L B CorbeilD G Guiney
Jun 1, 1986·Journal of Bacteriology·E GertmanA M Kropinski
Jun 1, 1993·Microbiological Reviews·R W Titball

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.